- Exchange: Frankfurt
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Ablynx NV+ Add to Watchlist
4AY:GR9.334 EUR 0.126 1.33%
As of 03:18:03 ET on 03/14/2014.
Company Profile for Ablynx NV (4AY)
Ablynx NV is a biopharmaceutical company. The Company discovers and develops therapeutic protein treatments for human diseases.
Key Executives for Ablynx NV (4AY)
|Edwin MosesChief Executive Officer||Wim OttevaereChief Financial Officer|
|Josefin-Beate Holz "Josi"Chief Medical Officer||Marieke VermeerschAssociate Dir:Investor Relations|